Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gasser

Showing results (261-270 of 476) with videos related to

Pageof 48
Sort By:
The Lancet. Neurology|November 14, 2009
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteriaDennis W Dickson, Heiko Braak, John E Duda, et al.
Annals of Neurology|March 17, 2015
Polygenic risk of Parkinson disease is correlated with disease age at onsetValentina Escott-Price, , Mike A Nalls, et al.
Parkinsonism & Related Disorders|June 13, 2026
Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPARγ levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageingMadeleine Fandrich, Claudia Schulte, Meike Jakobi, et al.
Stereotactic and Functional Neurosurgery|September 16, 2008
Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical-shift imaging of cholineElvis J Hermann, Elke Hattingen, Joachim K Krauss, et al.
NPJ Parkinson'S Disease|September 15, 2025
Methodological validation of Miro1 retention as a candidate Parkinson's disease biomarkerLayla Drwesh, Giuseppe Arena, Daniel J Merk, et al.
Neuroscience Letters|March 31, 2004
Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's diseaseJens Carsten Möller, Candan Depboylu, Heike Kölsch, et al.
Cell Death & Disease|November 14, 2025
Chr:17q21.31 locus risk haplotype H1 susceptibility to ferroptosis is mediated by endolysosomal pathwayEldem Sadikoglou, Daniel Domingo-Fernández, Natalia Savytska, et al.
European Journal of Neurology|January 15, 2021
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s diseaseMilan Zimmermann, Leonie Köhler, Marketa Kovarova, et al.
NPJ Parkinson'S Disease|December 1, 2025
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson's diseaseKathrin Brockmann, Alice Ticca, Stefanie Lerche, et al.
Frontiers in Neurology|March 14, 2022
CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative BiomarkersStefanie Lerche, Milan Zimmermann, Isabel Wurster, et al.
Pageof 48

Showing results (261-270 of 476) with videos related to

Sort By:
Pageof 48
The Lancet. Neurology|November 14, 2009
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteriaDennis W Dickson, Heiko Braak, John E Duda, et al.
Annals of Neurology|March 17, 2015
Polygenic risk of Parkinson disease is correlated with disease age at onsetValentina Escott-Price, , Mike A Nalls, et al.
Parkinsonism & Related Disorders|June 13, 2026
Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPARγ levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageingMadeleine Fandrich, Claudia Schulte, Meike Jakobi, et al.
Stereotactic and Functional Neurosurgery|September 16, 2008
Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical-shift imaging of cholineElvis J Hermann, Elke Hattingen, Joachim K Krauss, et al.
NPJ Parkinson'S Disease|September 15, 2025
Methodological validation of Miro1 retention as a candidate Parkinson's disease biomarkerLayla Drwesh, Giuseppe Arena, Daniel J Merk, et al.
Neuroscience Letters|March 31, 2004
Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's diseaseJens Carsten Möller, Candan Depboylu, Heike Kölsch, et al.
Cell Death & Disease|November 14, 2025
Chr:17q21.31 locus risk haplotype H1 susceptibility to ferroptosis is mediated by endolysosomal pathwayEldem Sadikoglou, Daniel Domingo-Fernández, Natalia Savytska, et al.
European Journal of Neurology|January 15, 2021
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s diseaseMilan Zimmermann, Leonie Köhler, Marketa Kovarova, et al.
NPJ Parkinson'S Disease|December 1, 2025
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson's diseaseKathrin Brockmann, Alice Ticca, Stefanie Lerche, et al.
Frontiers in Neurology|March 14, 2022
CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative BiomarkersStefanie Lerche, Milan Zimmermann, Isabel Wurster, et al.
Pageof 48